Dunham Small Cap Growth Fund N (DNDGX)
22.97
+0.25
(+1.10%)
USD |
Nov 18 2026
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 1.24% | 85.45M | 0.36% | -- |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -9.851M | 13.20% |
Basic Info
| Investment Strategy | |
| The Fund seeks to maximize capital appreciation. The Fund seeks to achieve its investment objective by investing in domestic growth-oriented, small-capitalization common stocks of companies traded on U.S. stock exchanges or in the over-the-counter market. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Small Cap Growth |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Sm&Mid Cap |
| Peer Group | Small-Cap Growth Funds |
| Global Macro | Equity North America |
| US Macro | Small-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Small-Cap Funds |
| Fund Owner Firm Name | Dunham Funds |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fund Flows
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of November 19, 2026.
Asset Allocation
As of September 30, 2026.
| Type | % Net |
|---|---|
| Cash | 0.81% |
| Stock | 98.04% |
| Bond | 1.29% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | -0.15% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Fidelity Instl Government Portfolio I | 2.10% | 1.00 | 0.00% |
| Repligen Corp. | 1.85% | 172.67 | 6.47% |
| Mirion Technologies, Inc. | 1.73% | 17.43 | 4.68% |
| Semtech Corp. | 1.51% | 104.25 | -2.36% |
| AngioDynamics, Inc. | 1.49% | 11.32 | -1.48% |
| Dynatrace, Inc. | 1.48% | 45.35 | 5.00% |
| Valmont Industries, Inc. | 1.47% | 410.95 | 1.07% |
| Twist Bioscience Corp. | 1.46% | 116.35 | 3.88% |
| Fulton Financial Corp. | 1.44% | 23.38 | -0.21% |
| FormFactor, Inc. | 1.43% | 82.84 | -0.23% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.95% |
| Administration Fee | 37581.00 None |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 100000.0 None |
| Minimum Subsequent Investment | 0.00 None |
TTM Distributions
| Type | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Qualified Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Normal
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Qualified
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
LT Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Ordinary Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Non-Qual
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ST Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Interest
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Tax-Exempt
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ROC
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Other
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Total
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
As of October 31, 2026.
Basic Info
| Investment Strategy | |
| The Fund seeks to maximize capital appreciation. The Fund seeks to achieve its investment objective by investing in domestic growth-oriented, small-capitalization common stocks of companies traded on U.S. stock exchanges or in the over-the-counter market. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Small Cap Growth |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US Sm&Mid Cap |
| Peer Group | Small-Cap Growth Funds |
| Global Macro | Equity North America |
| US Macro | Small-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Small-Cap Funds |
| Fund Owner Firm Name | Dunham Funds |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (11-18-26) | 0.00% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 113 |
| Stock | |
| Weighted Average PE Ratio | 42.57 |
| Weighted Average Price to Sales Ratio | 7.859 |
| Weighted Average Price to Book Ratio | 7.609 |
| Weighted Median ROE | -8.91% |
| Weighted Median ROA | -1.60% |
| Return on Investment (TTM) | -1.58% |
| Earning Yield | 0.0303 |
| LT Debt / Shareholders Equity | 2.939 |
| Number of Equity Holdings | 111 |
As of September 30, 2026
Growth Metrics
| EPS Growth (1Y) | 19.26% |
| EPS Growth (3Y) | 10.53% |
| EPS Growth (5Y) | 14.85% |
| Sales Growth (1Y) | 17.18% |
| Sales Growth (3Y) | 12.81% |
| Sales Growth (5Y) | 16.98% |
| Sales per Share Growth (1Y) | 45.31% |
| Sales per Share Growth (3Y) | 9.35% |
| Operating Cash Flow - Growth Rate (3Y) | 48.98% |
As of September 30, 2026
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:DNDGX", "name") |
| Broad Asset Class: =YCI("M:DNDGX", "broad_asset_class") |
| Broad Category: =YCI("M:DNDGX", "broad_category_group") |
| Prospectus Objective: =YCI("M:DNDGX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |